Cargando…
Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence
BACKGROUND: Symptom management in rheumatoid arthritis (RA) remains a complex challenge. Widespread use of cannabis-based medicines for a myriad of symptoms has fostered rheumatology patients' interest. However, their safety and efficacy in RA remain unclear. OBJECTIVE: The aim of this study wa...
Autores principales: | Schulze-Schiappacasse, Clara, Durán, Josefina, Bravo-Jeria, Rocío, Verdugo-Paiva, Francisca, Morel, Macarena, Rada, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860218/ https://www.ncbi.nlm.nih.gov/pubmed/33859125 http://dx.doi.org/10.1097/RHU.0000000000001745 |
Ejemplares similares
-
Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020) -
Living evidence in response to controversies about the use of antimalarials in COVID-19
por: Santillán-García, Azucena, et al.
Publicado: (2020) -
Evidencia viva como respuesta a las controversias en el uso de antimaláricos en COVID-19
por: Santillán-García, Azucena, et al.
Publicado: (2020) -
Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017) -
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer
Care
por: Abrams, Donald I.
Publicado: (2022)